Podcast appearances and mentions of Johnson Johnson

Carl Quintanilla, Jim Cramer and David Faber explored what to make of the markets extending losses after the worst day for stocks in almost a month. The anchors also reacted to Moody's cutting its China credit outlook to "negative" from "stable" -- and discussed the ramifications. The "Magnificent 7" in the spotlight: Apple jumps after Morgan Stanley says a smartphone recovery is "not yet priced into shares." Also in focus: Starbucks shares' eleven-day losing streak, "Investor Day" guidance from Johnson & Johnson and CVS Health, Nokia tumbles on news of an AT&T-Ericsson network deal, the new "Grand Theft Auto" trailer gets leaked. Squawk on the Street Disclaimer

Edith Wharton once said, "There are two ways of spreading light: to be the candle or the mirror that reflects it." Today's guest, Aaron Sherinian, is both—a candle igniting change and a mirror reflecting the light of others. Eleven years ago, Aaron was the Chief Communications and Marketing Officer for the United Nations Foundation, where, amongst many other things, he was instrumental in founding Giving Tuesday, a movement dedicated to turning the Tuesday after Thanksgiving into a day of giving. During these crucial early days for Charity Miles, Aaron observed the power of our community sharing the #GivingTuesday hashtag on social media, sparking his interest in our mission. This led to a breakfast meeting that was a turning point for Charity Miles and me personally. Aaron not only connected us with crucial sponsors like Johnson & Johnson but also provided platforms for us to share our story at events like the Social Good Summit, the Moms+Social Summit, and SXSW. These opportunities were instrumental in introducing us to key members of our community. I've wanted to do this interview for a long time, and it brings me particular joy to share it on Giving Tuesday. In this conversation, Aaron shares insights from his career and personal experiences, including: The potluck dinner of life and how each of us can bring our best dish. Effective ways to invite people to embrace positive change. Think big but start small. The evolving role of social media and its impact on social causes. Why rallies are important. The importance of cultivating a purpose posse. Overcoming taboos to find solutions. The power of showing up. The transformative power of taking a chance on someone. It's no exaggeration to say that Charity Miles would not exist today without Aaron taking a chance on us. In honor of Aaron, I invite you to take a chance on someone else you see spreading light into the world. #EveryMileMatters

-Vanessa Broadhurst, EVP, global corporate affairs, Johnson & JohnsonA highly decorated executive, Johnson & Johnson's Vanessa Broadhurst has been bestowed accolades by the likes of Savoy, blackdoctors.org, the National Association of Female Executives, who has recognized her as “Healthcare Champion of the Year,” and, of course, PRWeek, which this year is naming her to its Health Influencer 30 list.A key reason for all these honors: Her pursuit of health equity for everyone has been powerful and consistent throughout her career. That very career has also put Broadhurst in a unique position to observe and advise on ways to ensure the goal is consistently pursued. During this podcast, she shared myriad such insights.Though health equity has long been an issue, the recent pandemic truly shined a spotlight on how problematic it is. Few understand that as deeply as Broadhurst.“There's so much work to do on creating culturally competent care,” she notes. “And we need diversity in the healthcare workforce.”While many issues in need of vast improvement remain, Broadhurst is proud to note the strides that have been made, including those facilitated by programs such as J&J's Health for Humanity.She is pleased to report that there is greater diversity now in clinical trials. And she even speaks about progress made in the medical illustration arena.Broadhurst takes her role as a mentor to younger professionals very seriously, as well. She devotes time on this podcast to focusing on advice – both that she received in her early career and that she readily dispenses to the next generation.

Rachel Kaufman is the Senior Director, Global Sustainability at Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and technology industries. In this role, Rachel is responsible for establishing the company's environmental sustainability strategies and targets related to operations and products. She also oversees Avantor's broader Science for Goodness Sustainability Program and leads ESG reporting and customer and investor ESG engagement. Rachel's sustainability industry experience spans over 20 years. Before joining Avantor, she served as the Global Director of Environmental Sustainability for Johnson & Johnson's Consumer Health and Vision Care segments and managed communications and environmental policy for non-profit and government agencies in Washington, DC. Rachel holds a B.S. in NaturalResources from Cornell University and an MBA from the University of North Carolina, Chapel Hill. Rachel Joins Sustainable Nation to Discuss: Avantor's internal sustainability program: Science for Goodness Achieving consistent GHG reductions year over year How Avantor is addressing product use Avantor's responsible supplier program Advice and recommendations for sustainability professionals Rachel's Final Five Questions Responses: What is one piece of advice you would give other sustainability professionals that might help them in their careers?  Hopefully this doesn't come across as something that is obvious, but I would say, I view corporate sustainability quite differently than I view nonprofit work, environmental, conservation work. There is a business side of it. I decided to go back and get my MBA. I'm not saying that's what you need to do, but somehow really beef up that understanding of: what are the challenges that your functional and cross-functional partners are facing. What is it like to be the CFO? What might be their barriers to being able to approve the investment that you need to achieve your sustainability goals? Getting an understanding of the Head of Sales and HR and where their challenges are I think is really key to being able to have those conversations and progress quickly on sustainability goals.  What are you most excited about right now in the world of sustainability?  It's the spotlight, the debate and the day-to-day. The fact that in mass media right now, when you hear about these severe weather events, there's a mention of climate. When there's talk of the economy, there's a discussion of equity. It's really encouraging to see these topics get into the mainstream conversations on the related topics because they are so integral and so interrelated.  What is one book you would recommend sustainability professionals read?  I actually am not a huge reader of books. I get a lot of my information from reading articles, current events and podcasts. I would recommend folks follow some of the newsletters such as GreenBiz, Corporate Eco Forum, Sustainable Brands, and a top one I really like is actually the New York Stock Exchange. They do a top five ESG weekly roundup. I find that that's just a really great quick summary of what's happening in this space, particularly from that investor perspective. So I'm going to actually do a surprising plug for some of those email newsletters  What are some of your favorite resources or tools that really help you in your work?  One answer is the newsletters and the distributors that I just mentioned, but actually the sustainability network. We all have it, but I've joined a couple of sustainability groups of peers where we've been able to have these honest conversations of the challenges in a safe space. It is so helpful to hear that you are not alone in these challenges, and to be able to share learnings you have and be able to share confidentially and hear from others on how they have overcome some of the challenges. Find that network. Some are more structured than others where you can ask for those honest conversations. There's a few that I'm a part of that other folks you've had on the phone are a part of and we have spoken to about achieving these targets together.  Where can our listeners go to learn more about you and the work being done at Avantor? Our corporate website, which is avantorsciences.com. It's actually getting an overhaul soon, but it has a bunch of sustainability information under the “About Us.” Then of course you can follow myself or Avantor on LinkedIn. We do post quite a bit about our sustainability, DEI, and the work that we're doing in this space on LinkedIn.

Over three days in the fall of 1982, seven healthy people in the Chicago area died suddenly. At first, medical examiners were baffled but soon realized all the victims had taken Extra-Strength Tylenol capsules. Public trust in the medication vanished overnight. Johnson & Johnson, the makers of Tylenol, had to act fast if they wanted to save lives and their product.This season we've been sharing stories about companies and organizations that made mistakes and lost public trust. In this episode, we're looking at a company that did nothing wrong but had to find a way through a crisis to rebuild trust. Veteran Chicago news reporter Phil Rogers recalls how the Tylenol Murders terrified the nation and how Johnson & Johnson managed the crisis. OneTrust's Chief Trust Architect, Andrew Clearwater, examines how Johnson & Johnson defied the odds and actually strengthened trust in their brand.

Sarah Hughett joins Jimmy to talk about their shared experience as communication majors at the University of Indianapolis. She recalls the skills she learned by joining Speech & Debate at UIndy, still using them on a daily basis in her latest career working for Johnson & Johnson. They also share their guilty pleasures & favorite memories of being on staff at WICR-FM. Full episode is available now! Rate, Review, Subscribe & Donate! #jbkonair Link - https://linktr.ee/jbkonair --- Support this podcast: https://podcasters.spotify.com/pod/show/jbkonair/support

Quality control is one of those things that only a select few people pay attention to—until something goes wrong, then everyone cares. That's especially true in the drug manufacturing industry, where episodes like cross-contamination in a drug factory can shut down a production line and create instant shortages of important medicines. And if a contaminated medicines ever does get shipped out to clinics or stores, people's lives can be at stake. So drug makers are usually pretty receptive toward any new technology that can help them detect manufacturing problems before they get out of hand.That's the market opening that Harry's guest Taylor Chartier says she saw back in 2020, during the coronavirus pandemic. Chartier watched the stories about the Baltimore company Emergent BioSolutions, which was manufacturing vaccines for Johnson & Johnson and AstraZeneca and had to throw out millions of doses of both vaccines due to suspected cross-contamination, and thought: there has to be a better way. So she started her own company. And today her startup Modicus Prime is partnering with top pharma companies to use new machine vision and AI capabilities to catch drug manufacturing problems faster.For a full transcript of this episode, please visit our episode page at http://www.glorikian.com/podcast Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.

On this edition of Stock Picks, Gary Booysen from Rand Swiss analyses Astral, Deree & Co as well as Johnson & Johnson. Stock Watch

We were live ahead of the The African American Male Wellness Agency Walk in Los Angeles talking to their director Jhade Barnes to talk about the need to improve access and care for African American Men. Since 2004, The AAMW agency has produced a 5K Walk & Run (The Walk) in over 15 cities as an awareness campaign to spotlight the fact that Black Men get Peripheral Artery Disease and Diabetes related amputations at 4x that of their white counterparts and die on average 12 years earlier than their white counterparts. They have incredible partners such as Johnson & Johnson and The Janssen Pharmaceutical Companies of Johnson & Johnson that provide free testing and information to help Black men live longer from preventable diseases like PAD. This year The Way To My Heart, EZ Care Link, and Philips Healthcare had the opportunity to provide support for this wonderful mission! Celebrity fitness trainer Dion Jackson was also at the event to help inspire better health through exercise. 

Have you ever heard of capping your revenue? Today's guest, Katherine Wintsch about knocked me out of my chair when she mentioned her method of keeping, and maintaining boundaries. We also talk about the side effects of positive self-talk, encouraging our families in a way that will actually benefit them, and so much more. What a fun conversation, and I look forward to hearing your thoughts on today's episode.   In this episode, you'll discover…  What is the key trait to winning at work and at home? (1:25) What is capping your revenue? (2:17) How does she find her balance? (4:35) Battles I want to win, vs battles I'm willing to lose. (17:13) Critical vs Cruel (25:25)   Katherines's Bio: Katherine Wintsch is the founder and CEO of The Mom Complex where she helps some of the largest companies in the world such as Walmart, Johnson & Johnson, Airbnb, and Lowe's develop better products and services for mothers. She is also the author of the popular book Slay Like a Mother – which Parade magazine named one of the “top 10 life-changing self-help books of the year.” Katherine's sought-after research on women and mothers has been featured by The Today Show, The New York Times, The Wall Street Journal, and Fast Company. However, don't let all the accolades fool you. She's also been through years of therapy, decades of self-doubt, and more than her fair share of tequila. Thankfully, she tamed her “dragon of self-doubt” and now she's helping other women do the same. Katherines Links: Slay Like a Mother Website The Mom Complex Website Slay Like a Mother Instagram Katherine's Blog   What's Next?  Are you struggling to win at both home and work? Maybe you're crushing it at work, but home life is tough. Or maybe home life is great, but work is challenging.  I want to give you 10 tips that I share with clients. Go to my website at www.corymcarlson.com/subscribe and download your free copy of “10 Ways To Win At Home and at Work.” Have you read ‘Rise and Go'? All leaders get knocked down from time to time, so this is a resource to help you get back up quicker. Check it out on Amazon. Also, if you have not checked out my first book, please do! It is called Win At Home First and you can purchase it on Amazon Here. Forbes Magazine rated it one of 7 books everyone on your team should read.

I'm excited to introduce our guest, Paul Epstein. He is a seasoned sports executive with a 15-year legacy in the NFL and NBA. From breaking revenue records at the Super Bowl to opening a billion-dollar stadium, Paul's journey is nothing short of extraordinary. He's not just a sports strategist; he's the mastermind behind the San Francisco 49ers Talent Academy and a renowned "Why Coach". As an award-winning speaker and one of SUCCESS Magazine's top thought leaders, Paul has transformed teams and companies, including Amazon, Disney, Johnson & Johnson, and even giants like NASA, the Lakers, and the Cowboys. His insights have graced ESPN, NBC, and Fox Business, making him a voice you can't afford to miss! Find more about Paul at https://www.paulepsteinspeaks.com or his socials! Instagram, Facebook, and LinkedIn.  https://www.linkedin.com/in/paulepsteinspeaks/ https://www.instagram.com/paulepsteinspeaks/ https://www.facebook.com/PaulEpsteinSpeaks Find Paul's book here! https://www.paulepsteinspeaks.com/books  

Tercera hora de Visión Global en Radio Intereconomía que dedicamos a nuestro consultorio de Wall Street con Marc Ribes de Blackbird. Analizamos valores como AMD, ASML Holding, Fox Factory Holding, Steakholder Foods, Meta, Progressive, Johnson & Johnson, Rivian, Neogenomics, Target, Wework Starbucks. Repaso a la prensa y a la actualidad de los mercados y terminamos con el último análisis de Wall Street con Samuel Abraldes, CEO de Socaire. Con él hablamos de la tendencia alcista que están experimentando los índices y que se ha reforzado de forma intensa tras el buen dato de IPC que ayer se publicó en Estados Unidos. Dato que aleja, de momento y hasta que acabe el año, una nueva subida de tipos. De hecho, los inversores empiezan a descontar que ya no va a haber más subidas y que los tipos van a bajar antes de lo previsto inicialmente. También analizamos la nueva corrección en el precio del crudo que también quita presión a los mercados y a los propios bancos centrales, ya que ayuda a tener la inflación a raya.

This week Tee is excited to welcome author and investigative journalist, David Steinman for a conversation about his powerful new book Raising Healthy Kids: Protecting Your Children from Hidden Chemical Toxins Every Day. David is the director of the Chemical Toxin Working Group and one of America's premier environmental activists. In his book, David shows how today's most popular items–from bubble baths to cereal to cleaning products and snack foods are contaminated with unacceptable levels of chemical toxins and pesticides, and he proposes alternatives and substitutes to keep your family safe. David reveals never-before-seen test results for major brands like Johnson & Johnson, Kellogg's, Tide, Clairol, and General Mills that identify exactly which products contain ingredients that are dangerous. He casts a wide net, showing how beauty products as well as food items can cause reproductive health issues in pregnant women, and that environmental exposures, particularly in schools, can have a profound impact on babies' and children's development.  In this conversation Steinman brings listeners up-to-date on the increased dangers we face in all aspects of our lives, and how we can make smart choices to protect our children and ourselves. Raising Healthy Children is an inspiring, informative, and user-friendly book that will help every family reduce their toxic exposures and ensure their health and well-being. Connect with David: Website LinkedIn Twitter Facebook Instagram YouTube David's Articles: https://healthylivingmagazine.us/ https://goodmenproject.com/author/david-steinman/ ___________________________________ Follow Therese "Tee" Forton-Barnes and The Green Living Gurus: Tee's Organics - Therese's Healthy Products for You and Your Home:  The Green Living Gurus Website  Instagram Youtube Facebook Healthy Living Group on Facebook Tip the podcaster! Support Tee and the endless information that she provides: Patreon Venmo: @Therese-Forton-Barnes last four digits of her cell are 8868 For further info contact Tee: Email: Tee@TheGreenLivingGurus.com Cell: 716-868-8868 DISCLAIMER: ANY INFORMATION PROVIDED HERE IS GENERAL GUIDANCE AND NOT MEANT TO BE USED FOR INDIVIDUAL TREATMENT. PLEASE CONTACT YOUR PROVIDER OR DOCTOR FOR MEDICAL ADVICE. Produced by Social Chameleon  

Recebemos Mario Ballarin, CFO Brasil na Johnson & Johnson Innovative Medicine, para mais um episódio da série "5 perguntas para o CFO"! Confira a nossa conversa e conheça mais sobre a trajetória de sucesso do Mario Ballarin, os desafios da área de Finanças em uma das maiores empresas farmacêuticas do mundo e as habilidades que ele considera necessárias para ser um CFO bem-sucedido no Brasil.

Get ready to dive into the world of captivating voices in this episode of Voice Over Par Charcha! We're thrilled to introduce our guest, Nimisha Sirohi, a seasoned Voice Artist & ActorEver been enchanted by a voice that just pulls you into a story? That's the magic Nimisha brings to her work. She's a pro freelance voice artist with over 12 years of experience, and she knows how to make words come alive with her voice.Her talent spans a wide range of projects, from ads and promos to audio dramas and audiobooks. Whether it's a warm and gentle tone, an authoritative voice, something sensual, or just a friendly chat, she's got it all covered.Nimisha's journey in the world of voice acting began 12 years ago, and since then, she has dedicated herself to mastering the art of vocal performance like no other. Her impressive portfolio includes renowned Indian and International brands such as Johnson & Johnson, Big Boss Trailer, G20 Logo Launch, Tata Capital, Alembic Pharmaceuticals, Asian Paints, Evara, Sunfeast, Taj Mahal Tea, Mitsubishi Electric, Maruti Nexa, Bournvita, Sprite, L'Oréal, Garnier, Lakmé, CORD USA, Haier, Surf Excel, and many more.Not only is she an award-winning voice artist, having won the India Voice Fest award for three years in a row (2020, 2021, and 2022), but she's also sharing her knowledge through workshops and courses on voice acting and communication in Mumbai and Chandigarh.If you're on the lookout for a voice artist for your project or if you're curious about the world of voice acting, Nimisha Sirohi is your go-to expert. For Voice Over projects & Training related queries, You can connect with her at nimishasirohi@gmail.com, contact number - (+91) 9833188599or Her Instagram Handle Don't miss this episode where Nimisha shares her passion and experiences in the voice industry. Subscribe, like, and hit the notification bell to stay tuned for this fantastic conversation!

Mike is excited about Cisco buying Splunk. Mike is NOT excited about Target. The guys talk about the IPO of Instacart. Are delivery services such as Uber Eats, Grub hub and Instacart the future or a fad? Is the Fedex dividend safe? All these questions are answered and so much more stock talk.

This episode features an interview with Patricia Corsi, Chief Marketing, Digital, and Information Officer at Bayer Consumer Health. She has over 20 years of international brand-building and digital experience in the consumer goods industry. Previously, Patricia served as the CMO of Heineken Mexico and held leadership roles at Unilever, Kraft, Johnson & Johnson, and Sony Music. In this episode, Kailey and Patricia discuss creating a frictionless consumer journey, how AI can accelerate capabilities, and building trust with consumers.-------------------Key Takeaways:When facing noisy and complex times, it's important to connect with consumers in a time and place when it's needed. Whether that's through apps or platforms, connectivity creates a frictionless consumer experience.Technology and data have helped us move away from a reactive state when it comes to healthcare. These tools help us have engaging conversations with consumers and create proactive health behaviors.Using data collected by AI, marketers can identify insights into how to best support consumers on their journey to better health.-------------------“We tend to be very reactive to our health, when we know we are getting older. This is the role that we need to play, especially now using data and technology. We can have a much more engaging conversation directly to the consumer and maybe, for the first time, change this behavior of people towards their health on being less reactive and a little bit more proactive.” – Patricia Corsi-------------------Episode Timestamps:‍*(03:03) - Patricia's career journey‍*(08:46) - Trends in the consumer experience journey at Bayer Consumer Health‍*(17:26) - How Bayer Consumer Health is implementing AI‍*(28:14) - An example of another company doing it right with consumer engagement (hint: it's Movember, Cadbury, and Spotify) ‍*(30:55) - Changes in consumer experience in the next 6-12 months*(32:41) - Patricia's recommendations for upleveling consumer experience strategies-------------------Links:Connect with Patricia on LinkedInConnect with Kailey on LinkedInLearn more about Caspian Studios-------------------SponsorGood Data, Better Marketing is brought to you by Twilio Segment. In today's digital-first economy, being data-driven is no longer aspirational. It's necessary. Find out why over 20,000 businesses trust Segment to enable personalized, consistent, real-time customer experiences by visiting Segment.com

I've always said that my journey to TEDx was more impactful than actually giving the talk itself; it was a journey in clarity and effective communication. I had to get across big ideas in only 12 minutes.  Today I'm joined by John Bates, a TED talk expert who explores the neurobiological principles of communication. Together, we unravel the secrets behind creating engaging, emotionally resonant speeches, and offer practical advice on connecting with your audience and embracing the fear that often accompanies public speaking. This conversation is full of insights for self-employed business owners looking to master the art of impactful communication and storytelling.   John Bates is a TED and TEDx speaker, Leadership Communications Executive Coach, Author, and Keynote Speaker with a deep focus on communication rooted in neurobiology. He is renowned for his coaching excellence in the TED format. His clients, including notable organizations like Johnson & Johnson's JLABS, NASA, US Navy Special Operations, GE Aviation, and Boston Scientific, highly recommend him as a premier leadership communications coach. John's expertise lies in alleviating speaking anxiety, fostering strong leadership presence, and cultivating trust, loyalty, and connection through effective communication. His science-based approach benefits both logical, introverted individuals, and ambitious thought leaders, enabling them to craft influential speeches. John also offers top-tier pitch coaching, with affiliations in prestigious programs like Johnson & Johnson Innovations JLABS and Cisco Global Problem Solver Challenge, empowering entrepreneurs to succeed in pitch competitions, secure VC funding, and obtain grants.   And be sure to subscribe to The Self-Employed Life in Apple Podcasts or follow us on Spotify or wherever you listen to podcasts so you don't miss an episode.   Everything you need can all be found at jeffreyshaw.com.   John Bates, thank you so much for being here! Remember, you might be in business FOR yourself but you are not in business BY yourself. Be your best self. Be proud and keep changing the world. Guest Contact – JohnBates.com  Your Amazing Itty Bitty Guide to Being TED-Worthy: 15 Essential Secrets of Successful Speaking Based in Human Neurobiology by John Bates Register for John's Free Weekly Mini-trainings John Bates on LinkedIn (in/johnbates) John Bates on Facebook (@ExecutiveSpeakingSuccess) John Bates on Twitter/X (@johnbates) John Bates on YouTube (@ExecSpeakingSuccess) John Bates on Vimeo (@johnkbates) Contact Jeffrey – SelfEmployedNewsletter.com Website Books Watch my TEDx LincolnSquare video and please share!   Valuable complimentary resources to help you –   ·       The Self-Employed Business Institute- You know you're really good at what you do. You're talented, you have a skill set. The problem is you're probably in a field where there is no business education. This is common amongst self-employed people! And, there's no business education out there for us! You also know that being self-employed is unique and you need better strategies, coaching, support, and accountability. The Self-Employed Business Institute, a five-month online education is exactly what you need. Check it out! ·       Take The Self-Employed Assessment! Ever feel like you're all over the place? Or frustrated it seems like you have everything you need for your business success but it's somehow not coming together? Take this short quiz to discover the biggest hidden gap that's keeping you from having a thriving Self-Employed Ecosystem. You'll find out what part of your business needs attention and you'll also get a few laser-focused insights to help you start closing that gap. ·       Have Your Website Brand Message Reviewed! Is your website speaking the right LINGO of your ideal customers? Having reviewed hundreds of websites, I can tell you 98% of websites are not. Fill out the simple LINGO Review application and I'll take a look at your website. I'll email you a few suggestions to improve your brand message to attract more of your ideal customers. Fill out the application today and let's get your business speaking the right LINGO! Host Jeffrey Shaw is a Small Business Consultant, Brand Management Consultant, Business Coach for Entrepreneurs, Keynote Speaker, TEDx Speaker and author of LINGO and The Self Employed Life (May 2021). Supporting self-employed business owners with business and personal development strategies they need to create sustainable success.

Customer expectations are growing as economic stress factors remain, giving rise to an uncertain holiday season.   Retailers face their peak period during this season of shopping and shipping. This year appears to be shaping up like few others. Inflation remains a concern, interest rates continue to rise, and retailers are worried about weakened spending. So, where do things stand now? Do shippers expect this season to be naughty or nice?   In this episode, hear from the Assistant Professor of Professional Practice at Rutgers Business School, Dr. Tony Bell. Dr. Bell has 30 years of experience in supply chain operations and management with Johnson & Johnson, the Coca-Cola company, Whirlpool, and Maersk. And Old Dominion's Senior VP of Sales, Steve Hartsell. Steve has over 20 years of experience and has held multiple positions, including Director of OD Expedited and Service Center Manager.   Key Takeaways:   What can we expect for the holiday shopping season, based on the fall shipping season? [1:15]   Have post-COVID-19 supply-chain issues been solved? [3:21]   Are manufacturers and retailers managing their inventories sufficiently despite the multiple supply chain risks? [5:27]   How can risk-mitigation strategies reduce supply chain challenges? [8:35]   What can retailers do to prepare for this holiday season? [10:08]   How are labor shortages impacting the overall supply chain? [10:59]   Resources: OD Outlook ODFL.com Cargo Shorts podcast  

Welcome to an interview with the author of The Sound of the Future: The Coming Age of Voice Technology, Tobias Dengel. In his new book, Tobias answers why voice technology is the next big thing in technology, as big as mobile a decade ago and the internet in the late 90s, fundamentally altering the way companies do business. Tobias connects the dots about this emerging paradigm to vividly illustrate how business leaders can stay ahead of the game, rather than scrambling to catch up, as voice technology gradually reveals its power, creating a host of new winners and losers.  Tobias Dengel is president of WillowTree, a TELUS International Company, a global leader in digital product design and development, with 13 offices in North America, South America, and Europe, headquartered in Charlottesville VA. The company has been named by Inc. magazine to the Inc. 5000 list of America's fastest-growing companies for 11 straight years. WillowTree, a TELUS International Company's clients include some of the best-known brands in the world, such as T Mobile, Mastercard, Capital One, HBO, Fox, Time Warner, PepsiCo, Regal Cinemas, Charles Schwab, Johnson & Johnson, Lidl, Wyndham Hotels, Hilton Hotels, Holiday Inn, Canadian Broadcasting Corp, Synchrony Bank, Edward Jones Investments, and National Geographic. These industry leaders trust WillowTree, a TELUS International Company to design and develop their websites, apps, internal systems and voice interfaces. Get Tobias' book here: https://rb.gy/y4p29 The Sound of the Future: The Coming Age of Voice Technology Here are some free gifts for you: Overall Approach Used in Well-Managed Strategy Studies free download: www.firmsconsulting.com/OverallApproach McKinsey & BCG winning resume free download: www.firmsconsulting.com/resumepdf Enjoying this episode? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo

¡Emprendeduros! En este episodio Rodrigo y Alejandro nos dan una actualización de mercado donde hablan de la situación del mercado, la advertencia de Jamie Dimon, el discurso de Jerome Powell, los números de consumo y el crecimiento en China. Nos dan los reportes de ingresos de los bancos, United Airlines, Lockheed Martin, Johnson & Johnson, Tesla, Netflix y Proctor & Gamble. Después hablan de la bancarrota de Rite Aid y del nuevo lanzamiento a la bolsa de Didi. Finalmente nos dan la actualización de Cryptos donde hablan del boom inesperado de Bitcoin, de los cambios en Uniswap y de buenas noticias saliendo de FTX antes del potente análisis técnico de Delox. ¡Síguenos en Instagram! Alejandro: https://www.instagram.com/salomondrin Rodrigo: https://www.instagram.com/rodnavarro Delox: https://www.instagram.com/deloxelhumilde Emprendeduros: https://www.instagram.com/losemprendeduros

Is inflation blinding investors to a potential fiscal crisis? We have two heavyweights on the controversial topic. Plus, bitcoin crossing above $30,000 for the first time in months. We'll ask former CFTC Chairman Tim Massan about the path forward for regulation. And the second half of big bank earnings are on deck tomorrow. We have the action the story and the trade on two big names, plus Johnson & Johnson and Lockheed Martin.

Welcome to episode #901 of Six Pixels of Separation - The ThinkersOne Podcast. Here it is: Six Pixels of Separation - The ThinkersOne Podcast - Episode #901. Navigating the ever-shifting landscape of branding is challenging. Few understand this terrain better than Allen Adamson. With extensive experience in both corporate and academic settings, he offers a unique lens through which to understand the challenges and opportunities that today's businesses face. Allen has contributed to the success of global players such as GE, Johnson & Johnson, and FedEx, with a focus on identifying and delivering what truly matters to audiences. His latest book is Seeing The How - Transforming What People Do, Not Buy, To Gain Market Advantage. Allen makes the compelling case for customer experience as a strategic differentiator. His insights arise from years of multi-sector experience, beginning in the supermarket aisles of Unilever, progressing through advertising firms, and culminating in senior leadership at Landor Associates. As an adjunct professor at NYU's Stern School of Business and Cornell University, Allen shares his insights by adding academic rigor to practical expertise. He's not just a thought leader... he's a practitioner dedicated to actionable solutions. His past books include, BrandSimple, BrandDigital, The Edge, and Shift Ahead. He serves as an expert witness in litigation concerning brand assets and has the trust of media outlets ranging from CNBC to The New York Times. Co-founder and managing partner of Metaforce, Allen brings together a consortium of top-tier industry talent, tasked with identifying and executing high-impact customer experiences. In this episode, we delve deep into the transformative potential of aligning customer experience with brand promise. It's a conversation for anyone invested in the future of building a smarter business through branding and market leadership. Enjoy the conversation... Running time: 54:06. Hello from beautiful Montreal. Subscribe over at Apple Podcasts. Please visit and leave comments on the blog - Six Pixels of Separation. Feel free to connect to me directly on Facebook here: Mitch Joel on Facebook. Check out ThinkersOne. or you can connect on LinkedIn. ...or on Twitter. Here is my conversation with Allen Adamson. Seeing The How - Transforming What People Do, Not Buy, To Gain Market Advantage. BrandSimple. BrandDigital. The Edge. Shift Ahead. Metaforce. Follow Allen on LinkedIn. This week's music: David Usher 'St. Lawrence River'.

In this episode, we are delighted to have Arvind Balasundaram as our guest, who serves as the head of the Commercial Insights & Analytics (I&A) division at Regeneron, a pioneering biotechnology firm renowned for its groundbreaking medical innovations. Our conversation centers around data, analytics, and artificial intelligence (AI)'s pivotal role in the Life Sciences industry. Arvind shares his insights on the three significant shifts currently unfolding in the realm of data and analytics, and he delves into the crucial consideration of quantity versus quality when making data-driven decisions. Tune in to gain a deeper understanding of how the dynamics of this industry are transforming.   IN THIS EPISODE:   [4:06] Arvind discusses significant changes in data and analytics and focuses on the first major change. [8:18] The second major change is the evolution from small data to big data we can store.   [10:43] The third change is how much data we have to parse before we get to knowledge and how quickly we have to turn it around from input to output. [12:41] Arvind shares his thoughts on the quality versus the quantity of insights and what insights and analytics are all about. [17:56] Arvind discusses how you make choices on what data you select. [22:34] Arvind explains why decision-makers need to drop their biases regarding data curation, and he gives an example. [25:55] Arvind discusses the realm of possibility versus probability.  [33:44] Arvind explains what he sees as the challenges moving forward and how he sees mindset and culture changing.   KEY TAKEAWAYS   The concept of having more data is good; however, what is more important is getting the data you need, not just more and more in quantity. The cost of data can be prohibitive, so the selection of the data used is critical. Data that includes sentiment would be a more accurate way of doing insights and analytics in healthcare.   BIOGRAPHY: Arvind Balasundaram    Arvind leads the Commercial Insights & Analytics (I&A) group at Regeneron, a leading biotechnology company that invents life-transforming medicines for people with serious diseases. In this capacity, he oversees the implementation of deep insight frameworks and analytical capabilities to help bring the power of science and new medicines to patients who need them. A primary focus of the I&A group is to help realize Regeneron's mission to do well by doing good. Prior to Regeneron, Arvind also spent time at Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Pfizer, mainly on the early pipeline and launch side of the business. During his tenure at these companies, he participated in several industry-leading pharma brand launches, spanning diverse therapeutic areas.  Arvind earned his MBA from the Owen Graduate School of Management at Vanderbilt University. He also recently attained the Award of Achievement in Digital Analytics degree from the University of British Columbia (in association with the Digital Analytics Association) and a Certification in Data Science at UC Irvine (in association with Predictive Analytics World). He is a former Associate in the Applied Analytics Capstone program at Columbia University and a member of the Design Thinking Advisory Board at Rutgers University. Arvind is a past President of the Pharmaceutical Management Science Association (PMSA). His interests include exploring new capabilities to enrich the understanding of customer experience and engagement in omnichannel business ecosystems, staying engaged in the evolution of machine intelligence and AI, and identifying choice contexts and biases in noisy decision-making environments.    YOUR HOST: JASMEET SAWHNEY    Jasmeet Sawhney is a life sciences industry executive, marketing leader, and serial entrepreneur with deep roots in technology and data analytics. He is currently the global head of marketing at Axtria. Jasmeet has over 20 years of experience in the life sciences domain and has helped build and scale three successful companies. He has received several company and individual awards, including Inc 500, Deloitte Fast 500, Crain's NY Fast 50, NJBiz Fast 50, Business of the Year, SmartCEO Future 50, Top CMO, Forty Under 40, and many more.   Jasmeet Sawhney - LinkedIn   Axtria on LinkedIn   Arvind Balasundaram - LinkedIn

Welcome to Strategy Skills episode 388, an interview with the author of The Sound of the Future: The Coming Age of Voice Technology, Tobias Dengel. In his new book, Tobias answers why voice technology is the next big thing in technology, as big as mobile a decade ago and the internet in the late 90s, fundamentally altering the way companies do business. Tobias connects the dots about this emerging paradigm to vividly illustrate how business leaders can stay ahead of the game, rather than scrambling to catch up, as voice technology gradually reveals its power, creating a host of new winners and losers.  Tobias Dengel is president of WillowTree, a TELUS International Company, a global leader in digital product design and development, with 13 offices in North America, South America, and Europe, headquartered in Charlottesville VA. The company has been named by Inc. magazine to the Inc. 5000 list of America's fastest-growing companies for 11 straight years. WillowTree, a TELUS International Company's clients include some of the best-known brands in the world, such as T Mobile, Mastercard, Capital One, HBO, Fox, Time Warner, PepsiCo, Regal Cinemas, Charles Schwab, Johnson & Johnson, Lidl, Wyndham Hotels, Hilton Hotels, Holiday Inn, Canadian Broadcasting Corp, Synchrony Bank, Edward Jones Investments, and National Geographic. These industry leaders trust WillowTree, a TELUS International Company to design and develop their websites, apps, internal systems and voice interfaces. Get Tobias' book here: https://rb.gy/y4p29 The Sound of the Future: The Coming Age of Voice Technology Here are some free gifts for you: Overall Approach Used in Well-Managed Strategy Studies free download: www.firmsconsulting.com/OverallApproach McKinsey & BCG winning resume free download: www.firmsconsulting.com/resumepdf Enjoying this episode? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo

Câncer colorretal: Como a Johnson & Johnson e o A. C. Camargo aliaram IA para monitorar pacientes no pós-operatório

Paul Griffin is the Co-founder and CEO of The Sales Factory, a business development solutions company. The firm helps companies in multiple industries drive new business and accelerate growth by leveraging technology.  Paul has held marketing roles at various Fortune 100 and 500 companies, including Procter and Gamble, Johnson & Johnson, Nestle, and Kraft Heinz.  In this episode of the Smart Business Revolution Podcast, John Corcoran interviews Paul Griffin, the Co-founder and CEO of The Sales Factory, about how to excel in sales in an uncertain economy. They also discuss the challenge of building a structured remote team, the key breaking points at The Sales Factory, and how Paul leverages AI.

Lauren Livak Gilbert is the Director of the Digital Shelf Institute (DSI), which shapes the future of digital and advances commerce through community, content, and education. In her role, she defines the strategy for creating a global industry commerce community to support brands, retailers, and future leaders in the complex digital environment. As a thought leader in digital and design, Lauren has experience driving impactful multi-channel design content, transformative digital shelf solutions, and high-conversion web UX designs across multiple regions. Before DSI, she held numerous roles at Johnson & Johnson, where she owned the digital shelf for consumer products in North America. In this episode… Digital and eCommerce are necessary capabilities for brands, but integrating them at scale has become increasingly complicated. Some organizations position these functions in their IT departments, whereas others incorporate them in marketing or sales. How should you consider digital's role in organizational structures? Digital shelf expert Lauren Livak says that while you may integrate eCommerce into your IT department initially, it must expand throughout the business. Evaluating your organizational structure helps you determine its primary focus and consolidate digital capabilities within the specified area and the remaining departments. This should include cross-functional collaboration and involve every member of the company. With retail media extending throughout all major merchandisers, connecting your advertising efforts to digital is crucial. When considering eCommerce's position in your business objectives, prioritize your investments to target consumers in their most frequented channels rather than distributing your ad spend based on industry trends. In today's episode of The Digital Deep Dive, Aaron Conant chats with Lauren Livak Gilbert, the Director of the Digital Shelf Institute, about digital's place in organizational structures. Lauren talks about the barriers to rapid eCommerce acceleration, key shifts in organizational structures, and how to implement digital into business departments.

In der Nachmittagsfolge sprechen wir heute mit Felix Heinricy, Co-Founder und CBDO von Resourcify, über die erfolgreich abgeschlossene Series-A-Finanzierungsrunde in Höhe von 14 Millionen Euro.Resourcify hat eine SaaS-Plattform zur Verwaltung des Recyclings entwickelt. Durch die Digitalisierung der operativen Prozesse wird Unternehmen ermöglicht, ihr Recycling zu verwalten, zu verfolgen und zu verbessern. Dies reduziert den Verwaltungsaufwand und spart nach eigenen Angaben bis zu 40 % der Kosten im Vergleich zum traditionellen Abfallmanagement. Zudem verbindet das Startup globale Unternehmen mit lokalen Recyclern, um Sortierung und Recycling zu optimieren, bestehende Prozesse zu verbessern sowie nach eigenen Angaben hunderte von Arbeitsstunden pro Kunde einzusparen. Außerdem bietet die Recyclingplattform durch die Verbesserung der Prozesse die Möglichkeit, das Abfallaufkommen zu reduzieren. Dabei verfolgt das Unternehmen die Vision, eine Zero-Waste-Zukunft voranzutreiben. Resourcify wurde im Jahr 2018 von Felix Heinricy, Gary Lewis und Pascal Alich in Hamburg gegründet. Mittlerweile zählen Unternehmen wie McDonald‘s, Rewe, Hornbach und Johnson & Johnson auf die Lösung des Startups. Forbes bezeichnete das Nachhaltigkeits-Startup als Reverse Amazon. Resourcify hat bereits mehr als 500.000 Tonnen Abfall über seine Plattform abgewickelt und plant, die CO2-Einsparungen für seine Kunden und die Umwelt weiter zu steigern.Nun hat die Plattform für Entsorgungsmanagement in einer Series A 14 Millionen Euro unter der Führung von Vorwerk Ventures eingesammelt. Zu den weiteren Kapitalgebern zählen Revent, Ananda Impact Ventures, Speedinvest, BonVenture und WEPA Ventures. Mit dem frischen Kapital möchte Resourcify sein Software-as-a-Service-Angebot auf verschiedene Branchen ausweiten und sich weiterhin auf kritische Rücknahmeprogramme von Geräten und Abfällen konzentrieren, die es Unternehmen ermöglichen, ihre Nachhaltigkeitsziele zu erreichen. Außerdem möchte das Startup seine internationale Stellung in Europa und Großbritannien ausbauen. Dafür wird sich das Unternehmen auch auf den Ausbau seiner Vertriebsteams konzentrieren, wodurch auch der Umsatz gesteigert und die Recyclingerfahrung entlang der gesamten Wertschöpfungskette verbessert werden soll.

Alexander Bant is the chief of research for CFOs at Gartner, where his business insights are used by 45,000 leaders at a majority of the S&P Global 500. His research teams quantify and share what the top companies and their leaders do differently to maximize their people, processes and technology.Alex has interviewed more than 3,300 C-level executives and led strategy sessions at more than 250 companies, including Johnson & Johnson, Boeing, Salesforce, General Motors, The Walt Disney Company, Starbucks, Heineken, Deere & Company, Gilead Sciences, BMW, United Airlines, UPS, Philips, American Express, Verizon, Fidelity, McDonald's, Allstate and L'Oreal. Alex's data and findings have been featured in Forbes, The Wall Street Journal, The New York Times, Bloomberg, Fortune, Reuters, The Economist, Businessweek, CNBC, Yahoo Finance, USA Today and more than 75 other media outlets.Alex holds a degree from the London School of Economics (LSE) and is an adjunct professor at American University's Kogod School of Business in Washington, D.C.

This is part two of our globe-spanning story about drugs, patents, and YouTube megastar John Green. Quick recap: In our last episode, we learned how writer and YouTube star John Green kicked up a fight with Johnson & Johnson over a medicine called bedaquiline. And appeared to score a victory.Here, we dig into the backstory: How everything John Green and his fans won was built on activism going back 20 years, and spanning multiple continents. All of it illustrates how pharma companies work the patent system to extend their legal monopolies on medicine way beyond the standard 20 years, and how that leads to high drug prices here and abroad. And what we can maybe do about it. This episode starts in 2004, when India began the process of changing its patent laws to align with global trade rules. Activists there managed to carve out exceptions to the law to prevent some of the worst patent abuses. Fast forward to this year, when those legal safeguards become key to unlocking new doors in the fight against TB. Meanwhile, the proponents of those Indian safeguards are here in the U.S., pushing for drug patent reform here. Which not only could help Americans, but also influence global standards. Here's a transcript of this episode. Send your stories and questions. Or call 724 ARM-N-LEG.And of course we'd love for you to support this show. Hosted on Acast. See acast.com/privacy for more information.

My guest today is returning guest, Paul Epstein. Paul has spent nearly 15 years as a professional sports executive for multiple NFL and NBA teams, a global sports agency, and the NFL league office, where he has broken every premium revenue metric in Super Bowl history, opened a billion-dollar stadium, and founded the San Francisco 49ers Talent Academy, where he became known as the “Why Coach”. As an award-winning keynote speaker named one of SUCCESS Magazine's top thought leaders that get results, Paul's impact continues off stage providing leadership development and culture transformation programs for companies and teams including Amazon, Disney, Johnson & Johnson, NASA, the Los Angeles Lakers, and the Dallas Cowboys—and his work has been featured on ESPN, NBC, Fox Business, USA Today and today, Counsel Culture. He is also the best-selling author of “The Power of Playing Offense” and his book, “Better Decisions Faster”, comes out today! This conversation is decidated to Paul's journey, this conversation is what we make it. This is Counsel Culture.  Learn more at www.ericbrooker.com | www.paulepstein.com | www.thepurposesummit.com   

Nathan's excited to bring on another great marketing expert to the show. Mr. Shachar Meron has 20 years of experience as a branding, advertising, and marketing executive and has worked on 100+ brands, including well-known brands like TransUnion, Boeing, McDonald's, Intuit, Johnson & Johnson, Nordstrom, Cars.com, Motorola, and Abbott Labs. He currently serves as a Partner and Creative Strategist at Bluegreen Branding, where he helps brand and marketing leaders, primarily from tech and finance companies, create brands that stand out from all the noise. Shachar is also a Senior Lecturer who teaches advertising and brand strategy at the University of Illinois, where he also earned his BS and MS in Advertising. Over the past nine years, he has won several teaching awards. Enjoy the show! Host: Nathan A Webster Watch the Podcast on YouTube! LinkedIn | Instagram | Twitter | NDUB Brand    Download and subscribe on Audible, Google, iHeartRadio, iTunes, and Soundcloud. Please rate, review, and share!   Podcast Sponsored by https://letsconnectpnw.com/

[00:00:00] Tommy Thomas: A strong board of directors is essential to the success of any non-profit organization. The board of directors plays a critical role in providing guidance, oversight, and support for the organization's mission and operations.   There is no cookie-cutter or one-size-fits-all when it comes to Nonprofit Board Governance and Board Service.  However, there is a lot we can learn from people who are active on the Boards of high impact and highly effective nonprofit organizations.   Over the past 104 issues, we have devoted a lot of time to this topic.  From time to time, we will highlight excerpts from some of these conversations.   Today is the 3rd time we are compiling these excerpts.  I will have links to the previous two episodes in the Episode Notes.   Christin McClave has over 20 years of corporate leadership, beginning her career with Johnson & Johnson and serving in senior leadership in her family's large automotive aftermarket business – Cardone Industries.  Christin has served on and continues to serve on several nonprofit and corporate Boards. I've been in this business a long time and I've worked with probably 300 or 400 boards, over the last 30 years. And if I look at them, I would say a lot of the time they're males. They might be closer to my age than your age. And now things are changing. So, what are you seeing, or maybe what are you doing to lower the mean age on a board and to maybe bring more gender and ethnic diversity?  [00:01:43] Christin McClave:  So, I think we see a lot of changes in the general demographics, right?  As our society and culture are changing. The positive thing is there's so much more diversity coming up through the leadership ranks. And I think the traditional way that we've, I'll say we, because I've done it myself as well, when we've needed a new board member on a board, I instantly think about who have I worked with before? Who's like me, who thinks like me, who would be easy to plug and play into this board that I'm on? And so that's been our traditional way of pipelining onto boards. Let's find people who we know and who we know could be very quickly successful and contribute value to this board. I think what we've learned over the last couple years is that doesn't necessarily bring diversity to these boards that we are trying to diversify. And we've seen the pressure coming from the public sector the SEC, not quite regulations, but suggestions that we need a certain percentage of diversity on the public boards. And there's a lot of pressure in the market for that. And then that has trickled down its way to nonprofits and to the private sector. So, everyone is looking to diversify their boards at this point. And I think, a key piece of the job requirements that we have in the past always assumed on larger boards, I'll say. And most boards in general, everybody's wanted, okay you need to have a CEO or CFO or a C level executive. But preferably a CEO or CFO who's been in the chair before. And I've had people say that to me as well, that's what they're looking for. And I think we know just from sheer data that a lot of women and diverse candidates in general haven't had those opportunities. We are definitely developing that pipeline now and being very much more intentional. But I think like through the past few years and now looking at the talent market being as hot as it is and the demand for diverse talent we have, we are at the place we need to take a look at those very narrow criteria that we've said, oh, you have to be a C-level executive to be on a board and to be able to contribute value. And I think, now I've seen a lot more being written, a lot more being talked about, diversity coming onto boards where I'm reading someone's background and I'm like, wow, that is so cool. Maybe 10 years ago that person wouldn't have been chosen for that very significant board seat. So, I think we've opened up our criteria and have opened up our thought process and how we see people's experiences. We're looking at people's resumes really differently these days. From an HR perspective in internal, when we're screening candidates we took the requirement of having a college degree off of our requirements, probably, about 10 years ago, which was a little bit ahead of our time, but it just opened up our talent pool and we realized there are a lot of people out there that may not have a bachelor's degree but are way more experienced with their life and work experience that we were not being able to tap into because we had that very strict requirement. So, I think we're seeing that across the board at all levels, including at the board level. +++++++++++++++++++++++ [00:05:34] Tommy Thomas: Alvin Sanders, President & CEO of World Impact, a nonprofit that focuses on redemptive poverty and cultural proficiency in the urban community.  Alvin and his Board are huge proponents of the Policy Governance Model - an integrated board leadership paradigm created by Dr. John Carver.   I'm asking people these days about bringing younger people onto boards. And philosophically, do you have a position on that? And then I'll ask a follow up.  [00:06:10] Alvin Sanders: Yes, we try to hold it at nine, because we think a smaller board is better for getting things done. And I think in terms of thirds, a third of our board, we want gender diversity, a third of our board, we want age diversity, a third of our board, we want racial diversity. And then we want half and half, what I would say, marketplace people. These are business folk, and then the other half ministry people. Because if you have all marketplace people, the ministry gets lost. It's been my experience. And if you have all ministry people, the business of running the organization gets lost and it loses knowledge and expertise. So that's my philosophy of how you have you bring a board together. But you definitely need people, especially since I just read the other day that millennials now are the most dominant generation numbers wise. It's no longer Baby Boomers. It's never been my generation, Gen X. We're the forgotten generation, I think. Nobody gives a rip about Gen X, but Millennials now are it and you're just being silly if you don't have Millennials on your board. ++++++++++++++++++ [00:07:23] Tommy Thomas: Caryn Ryan, Managing Director at MissionWell, an organization that provides financial and strategic counsel to nonprofit organizations. Caryn is the former CFO for BP/Amoco and World Vision International.  She currently serves on corporate and nonprofit Boards.   I want to ask you one question then I'll close. So, my next to the last question has to do with succession planning and the board. At what point should that begin to occur? And how does the board address that without the CEO thinking “I'm a short-timer”? [00:08:04] Caryn Ryan: Okay. Yeah, that's great.  I'm dealing with that right now at one of the boards that I sit on. And I've just dealt with that last year as well. And it works both ways if it works all, all different ways. So let me just talk about one where the CEO does get the feeling. If you have this conversation that they're a short timer. I want to just say first of all, that can sometimes go back to the trust issue again, right? When there's a lack of trust between the board and the CEO then, and you bring up the succession of the question of succession planning, the first thing that goes of course into the CEO's mind is, oh, I'm getting fired.  I'm a short termer here.  So that has to again, be addressed, the trust issue, before you can have productive conversations around succession planning. But even longer term issues are going to take some time to get resolved. There's something you can always do on the succession plan that's very short term and that every single board must have in place. And that is you need a succession plan in case of an emergency. If your CEO becomes ill is hit by a bus, or whatever, you need an emergency succession plan that is an interim structure or very well thought through way that you'll manage in the absence of the CEO.  And usually, it's not going to bring out the same negative feeling for the CEO.  On the part of the CEO because they understand that, oh yeah, if I'm not there, we need to have some interim structure. And so, they'll begin helping the Board and thinking through, look, okay, if something happens to me, let's make this person on our staff the interim, or let's pull this Board Member out and see if they'll be the interim. Or they'll start to engage in the ideas for how that could work in interim a structure. And as long as you can get that interim structure put in place and everybody's in agreement that it's workable, that then gives a chance during the interim structure for the Board to go out and begin doing a search to find a replacement candidate. Regarding succession planning for a Founder – S/he just might not be willing to step aside. They might have created a whole lack of number twos in the organization who can step in, even in an emergency. It just may not be anybody. So that's a different situation where the board needs to probably, in addition to working on trust, which can be very difficult with the founder. You might be off the board if you start having those kind of conversations. But what you can do as a board is do your research. How would you do a search? You can get your research done on executive search firms who could step in and help you. You can just keep in mind, and Tommy, you're the one who should be telling your podcast listeners this, but it's a long process to do a search. You've got to set up a search committee. You got to figure out how you're going to recruit the person. You've got to have an approach. You have to execute it, you have to review the candidates. It's just really time consuming. You at least have to think through all of these, how that's a minimum thing, even if it's a founder situation. I'd say two things. Number one, for sure, have an interim emergency succession plan, no questions asked. That's an absolute minimum mandate for every board. And number two, if you're on a founder board, you have to do some special extra work along the side with networking, quiet networking, just to figure out the process and figure out how you would do, how would you do that if something did happen to your founder, if your founder's not willing to participate or help with that.  Does that make sense?  ++++++++++++++ [00:11:33] Tommy Thomas: Rich Stearns, President Emeritus at World Vision US.  Prior to joining World Vision, Rich was CEO for multiple organizations in the private sector, thus reporting to their Boards.  He cut his teeth on nonprofit Board Governance as President of World Vision US.   When I interviewed you back in 2017 you mentioned that from your perspective, the best thing that the World Vision Board did for you when you came on was you recalled an offsite retreat where y'all got introduced to each other. Could you share a little bit about that with us? I think we probably have a lot of up and coming CEOs listening and that might be an interesting discussion. [00:12:14] Rich Stearns: Yeah, I don't know how much that costs. Probably not much, but it was the best money World Vision ever spent. When I came into World Vision the Board and the CEO had what I'd call a turbulent relationship. He wasn't thrilled about his board and the way they behaved, and the Board wasn't thrilled about him in certain ways. And so, I was coming into kind of a troubled marriage, right? You could say there'd been a divorce, and I'm the new husband coming in. And so, the Board had enough wisdom to say, you know what, we should start off on the right foot here. Why don't we hire a board consultant to come in and do a two-day retreat with a new CEO to teach the Board and the new CEO, how best they should interact and communicate with one another. So, a friend of yours and mine named Bob Andringa, he's retired now, but he was in the Board consulting business. He's written at least one book, if not several. He came in and he conducted a Board Governance 101, 102 course for all of us. And gave us tools to use and dealt with different scenarios of here are the dos and don'ts for Board Members. Here are the dos and don'ts for the staff and the CEO. Here is the best way to understand your responsibility as Board Members. This is what your responsibility is, and this is what your responsibility is not. This is the role you play. This is the role you don't play. And same with a CEO, Rich, your role is this the board's role is to establish policy. I guess the best way to say it is it laid down the ground rules for a healthy relationship. And I don't think it's an exaggeration to say I had a 20-year honeymoon with my board. Not that there weren't an occasional, marital argument over the years. But it was like a 20-year honeymoon with the board. And I respected them, they respected me. My staff, when I first started, after a year, they said, boy, you've had a one-year honeymoon with this board. It's amazing. Because they'd seen some of the dysfunction in the prior years. And 20 years later, they were still saying you're still on your honeymoon. And I in terms of my response, what I attribute it to, is what I talked about earlier, Tommy, that the board knew they could trust me. I would never tell them a lie. I would never hide anything. I was completely transparent. Anything they wanted to talk about at a board meeting, we could talk about. Any numbers they wanted to see, we'd show them. If I had some bad numbers, I'd bring them to the board and say, look, this is not good, and here's what we're going to do.  They never felt I was hiding anything. And so that created trust as well. [00:15:03] Tommy Thomas: One of the guys that you've influenced over the years is Joe Mettimano at Central Union Mission. And when I interviewed Joe there, he talked about a lesson he learned from you about the president's report to the board. He would attribute part of his success to what he learned from you there. Tell us about that. [00:15:22] Rich Stearns: I started every board meeting with a president's report. So, the Board is gathered, in the case of World Vision they've flown in from all over the country, and here they are at the World Vision board meeting and remember, they're all volunteers, some are pastors, some are business people.  They're from all walks of life and so I tried to use the President's Report to basically bring them up to speed on what was going on at World Vision. What were the important issues? What were we doing about the important issues? How are the finances doing? I tried to answer as many questions as they might have in advance. Because the rest of the board meeting, the finance committee was going to meet and other committees were going to meet. And I tried to use the President's Report to cast a bit of a vision for where we were as an organization, where we're headed, what my outlook was for the coming year or the coming quarter. And I try to use the Board Meeting to really cast a vision to remind them of the mission of World Vision. Often, I would start with a trip report. I've just gotten back from the Syrian refugee crisis, and I want to tell you what I saw. I would remind them, we're sitting here in a nice boardroom, but people are dying all over the world. And our job is to intercede for them to help them to rescue those who are perishing as the book of Proverbs says. And so, trying to remind them why they were here, why World Vision was here and then look under the hood at, the financials, the numbers, the revenues, the overhead, and you had to deal with issues like real estate transactions and mundane stuff like that. I wanted to always to put it in the context of the bigger mission, vision and values of the organization. My President's Report would sometimes go 90 minutes to two hours which is a lot. But usually, the board would say that was the highlight of the meeting because that really brought them up to date on everything. +++++++++++++++= [00:17:16] Tommy Thomas: Paul Maurer, President at Montreat College.  Paul is a student of Board Governance and identifies as a “governance nerd”.  Paul is on his second college presidency and has learned a lot – some through the school of hard knocks about effective Board Governance.   And a lot of people that I talk with, there's a move toward lowering the mean age of the board and increasing diversity. What kind of experience have y'all had at Montreat around those issues? [00:17:45] Paul Maurer: We're intentionally trying to increase diversity. We've not found that to be an easy pathway, but we are we are committed to it. And on age I would just gently push back on the median age lowering. I'm very much of the Aristotelian camp that young people have less wisdom. And part of what you want for board members is wisdom. Wisdom comes with experience, and experience comes with age and the hard knocks of life and just the journey of life with gray hair and getting beat up occasionally. And I want younger people on the board, but that's less common. They're actually very hard to get on the board because they're less qualified candidates in my view, and they're uber busy with career and family. So, the young members, the 30 somethings, I have on my board, I have two of them. They're like up to their eyeballs, four or five kids each, they're CEOs or leaders in their own rights and rising in the ranks. And these people have large portfolios and enormous demands on their time. Then my 70- and 80-year-olds, and I even have a 91-year-old board member who I recruited at the age of 87. And he said to me, he said, Paul, what if I die? And I said, Bill what if I die? We're all going to die. You've got a lot of gas left in your tank. You've got enormous amount of wisdom. And you may have others who think that you're too old to be a board member. I don't think that at all. And if a day should come when your health has slipped, your metro capacities have slipped, we'll have that conversation and we'll have it openly and honestly. Honestly the seventies, eighties, and 90-year-old trustees I have are easily among my best trustees. They're phenomenal. [00:20:04] Tommy Thomas: Let's change over a little bit to the board aspect of being a president. What was the biggest adjustment that you had to make between, say, reporting to the CEO as a cabinet member and then as the President reporting to the Board? [00:20:20] Paul Maurer: Yeah, it's a great question. I'm a bit of a governance nerd. I really think about and study governance. I did that in my doctoral work. I do it as a college president in nonprofit governance. And so, the president needs clarity. What is the role of the board? What is the role of the president? What's the role of the relationship and what's the role of everyone else on campus in relationship to the board? And so, in the world of board governance, there are working boards and there are policy boards. Startups tend to have working boards, like true startups, like really small organizations. More established organizations. If they haven't transitioned to a policy board, they probably ought to consider doing so. Because you don't really want a board involved in the operations of an organization. And so, I'm deeply grateful that my board gave me the lead role in board development, meaning recruitment of new board members, training of board, the board policy manual. And we have a great board today, and they really understand that the board should not be involved in operations. That's the CEO's job but should be sure that they're being fiduciaries, that they're making sure there's a strategic plan that's being carried out their success along the way and that they manage or evaluate. They don't manage, they evaluate the presidents. They hire and fire the president, the CEO. I do think that my argument would be that it's more important for a President to be a CEO than a President. The President is, as I think of a bit of an old model for college leadership, it's rooted in what I think is not a very useful model of shared governance. I think the CEO is a better model, but you also need a CEO who's sensitive to campus dynamics and the idea that consensus really matters. And a consensus building CEO I think is the best model, but I think that the CEO also needs to be the CUO - the Chief Urgency Officer. Because things are changing so fast.    Links & Resources JobfitMatters Website Next Gen Nonprofit Leadership with Tommy Thomas Two Previous Best of Board Governance Episodes:  2023 – Best of Board Service Part 1 2023 – Best of Board Service Part 2 Episodes Featuring These Excerpts Christin McClave – Insights into Board Governance Rich Stearns – President Emeritus World Vision US – An Inauspicious Leadership Journey – Part 2 Alvin Sanders – Board Governance Caryn Ryan – Board Governance Paul Maurer – Board Governance   Connect tthomas@jobfitmatters.com Follow Tommy on LinkedIn

In this episode, we talk to Theresa Neil, Founder of Guidea. In this interview, we discuss easy improvements femtech founders can make to enhance their pitch decks, trends in branding design for femtech companies and how Femovate is truly backing the women's health movement.Remember to like, rate and subscribe and enjoy the episode!Guest bioTheresa is an O'Reilly author and is recognized as a “Top Designer in Technology” by Business Insider. Her client list includes Humana, Cigna, Johnson & Johnson and global biopharma companies. Her company Guidea, is an award-winning women-owned UX design consultancy specializing in Digital Health and FemTech. Organization bioGuidea, is an award-winning women-owned UX design consultancy specializing in Digital Health and FemTech. Alongside the day-to-day of Guidea, the team also apply their digital health expertise to advance the femtech industry and the wellness of 1 billion women through their Femovate program. FemTech Focus Podcast bioThe FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women's Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women's health and wellness.FemHealth Insights bioLed by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women's health market.Time Stamps[03:37] Theresa's background[07:13] Guidea's services[09:59] What is Femovate?[16:22] Trends in Femovate applications[21:00] Feedback from Femovate clients and applicants[26:34] Unique UI & UX features specific to women's health [35:08] User research for women's health compared to other industries[39:18] Brand design trends in FemTech[43:17] Stereotypical feminine imagery[44:33] Future vision for Femovate[46:00] What's an area that still needs innovating?[48:55] What does femtech need to be successful?Call to Action!Apply to Femovate by September 18! femovate.comDon't forget to subscribe to the FemTech Focus podcast, and leave us a review!Sponsor InfoThis episode is brought to you by Guidea your go-to UX design consultancy specializing in digital health innovation. Guidea isn't just any design firm. They're a women-owned, women-led powerhouse team that's partnered with 20 of the Fortune 100 companies and impacted over a billion lives through dozens of live products, clinical trials, and even FDA approvals.Speaking from personal experience, the Guidea team excels in translating your vision into transformative solutions that not only win awards but significantly improve outcomes. And, driven by their passion for health equity, Guidea is also the team behind Femovate, a sponsorship program focused on uplifting underrepresented founders and reaching underserved populations. They've already collaborated with over 30 Femtech startups across 14 different verticals, offering personalized, one-on-one mentorship and guidance in UX research, strategy, and design.So, if you're in the Femtech space—whether you're just starting out or scaling up—Guidea wants to hear from you.Don't miss this chance to work with a team that's as committed to your vision as you are. Visit www.guidea.com and let's raise the standard for digital healthcare, together.Episode ContributorsTheresa NeilLinkedIn: @Theresa NeilGuideaWebsite: https://guidea.com/LinkedIn: @GuideaTwitter: @TeamGuidea  FemovateWebsite: https://www.femovate.com/LinkedIn: @Femovate by GuideaDr. Brittany BarretoLinkedIn:  @Brittany Barreto, Ph.D.Twitter: @DrBrittBInstagram: @drbrittanybarretoFemTech Focus PodcastWebsite: https://femtechfocus.org/LinkedIn: https://www.linkedin.com/company/femtechfocusTwitter: @FemTech_FocusInstagram: @femtechfocusFemHealth InsightsWebsite: https://www.femhealthinsights.com/LinkedIn: @FemHealth Insights

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: John Green & Grassroots Activists Pressure Danaher To Drop Price of Tuberculosis Test, published by Gemma Paterson on September 12, 2023 on The Effective Altruism Forum. Really great piece from Good Good Good on the campaign to pressure Danaher to reduce the price of their TB test. Excited to see the outcome! Tuberculosis is the world's deadliest disease - and it is entirely curable. The airborne disease has plagued human history, and the World Health Organization estimates that 10 million people across the globe are infected by TB every year. Of those millions, 1.6 million still die each year, despite the existence of life-saving technology and medicine. These are facts that enrage many - but especially author and philanthropist John Green. "Why am I passionate about TB? It's the deadliest disease in human history, but for most of human history we couldn't do much about it. However, since the mid-1950s, TB has been curable - yet we still allow TB to kill over 1.6 million people per year," Green told Good Good Good. "This is horrifying to me. I don't want to accept a world where we know how to cure Tuberculosis but deny millions of people access to that cure." This passion was put on display in July of this year. Through the social media campaign #PatientsNotPatents, Green and his fanbase - called Nerdfighters, or Nerdfighteria in collective form - followed the lead of TB advocates to call on drug company Johnson & Johnson to allow the sale of generic bedaquiline - a life-saving TB drug that had been inaccessible under the company's patent for over a decade. Nerdfighteria - as well as longtime TB organizations such as the Stop TB Partnership and TB-survivors Phumeza Tisile and Nandita Venkatesan - was successful, and Johnson & Johnson ended its reign on bedaquiline (though advocates are still working to ensure that all low- and middle-income countries receive access to the generic drug). To end the TB epidemic by 2030 - a goal shared by both the WHO and the United Nations - more pharmaceutical companies need to do their part to make healthcare more accessible, especially in countries with a high TB burden. So, in their effort to end TB, Nerdfighteria has taken on a new company: Danaher. The Issue Danaher is a multinational corporation, founded by brothers Steven and Mitchell Rales, that owns a number of other large companies, such as Cepheid, Pantone, and X-Rite. (Steven Rales also founded Indian Paintbrush Films, which has financed many of Wes Anderson's movies.) Most relevant to this campaign, however, is that in 2006, Danaher and molecular diagnostics company Cepheid created the most helpful diagnostic resource for TB: The GeneXpert machine. This rapid molecular testing machine is able to test for a number of infectious diseases, including COVID, HIV, TB, and multidrug-resistant TB. In fact, the WHO recommends Xpert tests as the initial test for all people with signs and symptoms of TB. The GeneXpert machine itself is cost-effective, but its testing cartridges are more costly. The company charges about $10 per regular TB testing cartridge and about $15 per multidrug-resistant TB testing cartridge (though both tests cost the same to manufacture). According to a 2019 brief from Doctors Without Borders, Danaher and Cepheid could reduce the cost of these cartridges to just $5 each - or lower - based on continuous increases in volume. The brief said a "20-30% reduction in price may be overdue" thanks to expansion in volume. "These pricing packages serve to expand Cepheid's footprint . and do nothing to address the urgent need to scale up affordable testing for COVID-19, TB, and other diseases, or to address the longstanding lack of affordability and unfair pricing of Xpert tests," David Branigan, of activist organization Treatment Action Group, said in a statement in 2...

Paul Epstein has spent nearly 15 years as a professional sports executive for multiple NFL and NBA teams, a global sports agency, and the NFL league office, where he has broken every premium revenue metric in Super Bowl history, opened a billion-dollar stadium, and founded the San Francisco 49ers Talent Academy, where he became known as the “Why Coach”.As an award-winning keynote speaker named one of SUCCESS Magazine's top thought leaders that get results, Paul's impact continues off stage providing leadership development and culture transformation programs for companies and teams including Amazon, Disney, Johnson & Johnson, NASA, the Los Angeles Lakers, and the Dallas Cowboys—and his work has been featured on ESPN, NBC, Fox Business, and in USA Today. He is also the best-selling author of “The Power of Playing Offense” and is slated to launch his second book in 2023, “Better Decisions Faster”.During the interview we discuss…the head-heart-hands equationovercoming decision fatigue and indecisionthe most valuable decisions (MVDs) that separate successful businessesauthenticity and collaborationbuilding high-trust teamspersonal and professional wellbeingGet in touch after the interview…LinkedIn: https://www.linkedin.com/in/paulepsteinspeaksInstagram: https://www.instagram.com/paulepsteinspeaksWebsite: https://www.paulepsteinspeaks.comGet Paul's new book, Better Decisions Faster https://www.amazon.com/Better-Decisions-Faster-Unshakable-Confidence/dp/1637555733Want to become more confident? Check out the Confidence Quiz. It will score your confidence on a scale of 1-100. After you complete the quiz, you'll receive a collection of tools, resources, and activities to help you become the most confident version of yourself. https://www.paulepsteinspeaks.com/confidence-quizClaim your free gift!We're giving away a one-year membership to the world's #1 business book summary service for leaders! Our gift will help you stay on top of the latest ideas, decide which books to read next, and engage your teams.To get your gift:Leave a rating or review on your favorite listening channel.Take a screenshot of your review.Share the screenshot on LinkedIn, and mention either “Allison Dunn” or “Deliberate Directions” and the “Deliberate Leaders Podcast”.=============Allison DunnExecutive Business CoachDeliberate Directions + Executive Business Coaching + Training Center3003 W Main Street, Suite 110, Boise ID 83702(208) 350-6551Website https://www.deliberatedirections.comLinkedIn https://www.linkedin.com/in/allisondunnPodcast https://podcasts.apple.com/us/podcast/deliberate-leaders-podcast-with-allison-dunn/id1500464675

Episode 149: COVID Vaccines UpdateFuture Dr. Williams presented an update on COVID-19 vaccines. This update is only for immunocompetent individuals, and it was recorded on August 24, 2023. Dr. Arreaza added comments and insight.  Written by John Williams, MS4, Ross University School of Medicine. Editing by Hector Arreaza, M.D.  You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Currently, there are two types of vaccines that have been approved by the FDA:Moderna and Pfizer developed mRNA vaccines.Novavax developed a lesser-known protein subunit vaccine.As of May 6, 2023, the vaccine developed by Johnson & Johnson has expired and is not available in the U.S.Novavax: This vaccine contains pieces (proteins) of the virus that causes COVID-19, the spike protein plus an adjuvant. It works by activating the immune system against the spike protein, so it will be ready to fight the actual virus when you get infected. Regardless of vaccine type, the shots are administered in the upper arm and have been demonstrated, for most people, to be safe and effective. There have now been hundreds of million vaccines administered in the US alone and the effectiveness of the vaccine to reduce the risks of severe illness, hospitalization, and death has been well documented. The most common side effects consist of mild to moderate cases of fever, chills, headache, and tiredness that are self-resolving.What is new about COVID-19 Vaccines?The updated vaccine is known as “bivalent”. This term is important because it refers to the vaccine's ability to confer protection against both the original COVID-19 virus as well as new variants Omicron BA.4 and BA.5. Rollout of the updated vaccine began in September 2022 for those aged 12 years and older and became widespread in March 2023 with approval granted for use in children aged 6 months – 4 years. Selected individuals over age 65 or those who are immunocompromised may receive additional doses to provide comparable and safe protection. The receipt of the updated vaccine supersedes any previous doses and provides coverage against the most recent known variants determined to be either most widespread or that have been projected to be more prevalent.Children aged 6 months – 4 years who received the original Pfizer vaccineThose who received either 2 or 3 doses of the original vaccine should receive 1 dose of the updated vaccine.Those who received 1 dose of the original vaccine should receive 2 doses of the updated vaccine.You are considered up to date if you have received 3 vaccine doses, including at least 1 updated dose.Children aged 5 years who received the original Pfizer vaccineThose who received 1+ doses of the original vaccine should receive 1 dose of the updated vaccine.You are considered up to date if you have received at least 1 updated dose.Children aged 6 months – 4 years who received the original Moderna vaccineThose who received either 2 or 1 dose(s) of the original vaccine should get 1 updated vaccine.Children aged 5 years who received the original Moderna vaccineThose who received either 2 or 1 dose(s) of the original vaccine should get 1 updated vaccine.Unvaccinated children 6 m-4 years should receive the new bivalent vaccine, 2 doses ofModerna or 3 doses of Pfizer, but if you are 5 years old and unvaccinated, you will receive 1 dose of Pfizer or 2 doses of Moderna.For 6-11 yo patients who have been vaccinated with 1 or more doses of monovalent (Moderna or Pfizer) will receive 1 dose of Bivalent Moderna or Pfizer. If you already received 2 monovalent doses and 1 bivalent dose, you are done, no more vaccines are needed. If you have not received any COVID-19 vaccine and you are in this age group (6-11 yo), you only need 1 bivalent dose, and you are done.>12 yo and Adults. If you received 1 or more doses of monovalent or if you are not vaccinated, you need 1 dose of bivalent (Pfizer or Moderna). If you already had 2 doses of monovalent and 1 dose of bivalent, you are done!An FDA advisory committee convened on June 15, 2023, to discern the importance for additional updates to the most recent COVID-19 vaccine series. It was determined that the latest circulating variant currently making rounds is from the Omicron group known as XBB. The committee decided it is prudent to proceed with a preference for the XBB 1.5 variant. The updated vaccine will be a monovalent version available in the Fall of 2023. As with the previous version, the FDA will provide strict oversight and safety monitoring of the vaccine._______________________________Conclusion: Now we conclude episode number 149, “COVID Vaccines Updates.” Future Dr. Williams explained that the bivalent COVID vaccines are currently recommended for unvaccinated patients, or for those who were previously vaccinated with monovalent vaccines. This episode focused on patients who are NOT immunocompromised. We encourage our audience to check the CDC website for recommendations about patients who are immunocompromised.As a clarification, our sub-intern, John Williams, has a great sense of humor and he claimed to be the composer of the music for many famous Hollywood movies. We don't doubt his musical talent, but we must make clear that it was a joke! This week we thank Hector Arreaza and John Williams. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Tin, Alexander, New COVID vaccine and booster shots for this fall to be available by end of September, CBS Texas, published online on August 9, 2023. https://www.cbsnews.com/texas/news/covid-vaccine-booster-xbb-variants-september-2023/, accessed on September 7/, 2023.Center for Disease Control and Prevention, Overview of COVID-19 Vaccines, updated May 23, 2023, https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-COVID-19-vaccines.html, accessed on September 7, 2023.Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2023, United States Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2023, accessed on September 7, 2023.Royalty-free music used for this episode: Gushito - Latin Chill. Downloaded on July 29, 2023, from https://www.videvo.net/  

This episode is special. When we heard that widely-beloved writer John Green was rallying his online community around a fight over drug prices — and apparently making a difference — we were pumped. And this story took us in so many different directions: Literally around the world, and then straight back home.The drug in question is bedaquiline, made by Johnson & Johnson. It treats drug-resistant tuberculosis, and its price has been a huge obstacle to getting it to places it's needed most — primarily places far away from the U.S.But the reason this TB drug costs so much overseas is also one of the main reasons that important drugs here are so expensive — drugs like insulin, Humira and… well, just about everything: Legalistic patent games that pharma companies have mastered. So, in addition to John Green — and yes, we talked with John Green — we also talked with one of the world's leading experts on drug-patent games, Tahir Amin.Also, John Green is a great storyteller. So hearing him tell the story of how he became obsessed with tuberculosis is bittersweet.And in order to make sense of any of this, we had to dig into the story of how John Green and his brother Hank became (and remain) YouTube superstars. For more than 16 years, they've been building a community of “nerdfighters” — nerds fighting to make the world a better place. It's a profoundly sweet and fun story, and everything we're trying to do here owes them a debt. Oh, finally: This is, as you're probably guessing by now, an epic story. It's gonna take two full episodes of An Arm and a Leg to tell it all. So, we hope you enjoy part one. There's more coming in a few weeks. Hosted on Acast. See acast.com/privacy for more information.

This week our host Brandi Starr is joined by Stosh D. Walsh, Founder and Managing Principal at Constant Organizational Development.   Stosh D. Walsh serves leaders and their organizations as a consultant, coach, facilitator, speaker, and writer.  His direct, insightful, and encouraging style invites individuals and organizations to live with greater courage and create the best world they can envision.   He began his career in traditional education settings, honing his leadership as a classroom teacher for middle school through college, and as a university residence life director and athletics coach. After those experiences, he spent nearly a decade with The Gallup Organization as part of their executive leadership practice, where he contributed to the best-selling Strengths Based Leadership, won several awards as Gallup's top presenter in his practice category, and published 2 articles: Five Questions You Must Ask Your Team". Gallup Business Journal, May 2013-subsequently named top read article of 2013, and "Leadership is More Than the C-Suite". Gallup Business Journal, September 2013.    Stosh is an expert in strengths-based organizational development, including leadership and executive coaching, employee engagement, and talent management, having spent thousands of hours consulting, coaching, and training on each.  He has also been a TEDx speaker and is the author of Along the Way: Leadership Stories from Everyday Life (2012).   Over the course of his career, Stosh has delivered keynotes, facilitated workshops, and coached leaders in both non-profit and for-profit organizations, including many Fortune 500 companies.  His experience spans a wide variety of industries, including healthcare, financial services, automotive, government, retail and manufacturing, a partial client list of which includes GE, HP, Boeing, Microsoft, Cardinal Health, Johnson & Johnson, State Farm, Caterpillar, Northrup Grumman, Alcoa, Johnson Controls, US Bank, Old Navy, Banana Republic, Waste Management, Kiewit, Stryker, Eastman Chemical, Harley Davidson, Charles Schwab, McKinsey, Federal Aviation Administration and Kohler.   Stosh's formal education includes a BA in Education and an MA in Leadership.  His other interests include photography, hiking, tattoos, good whisky, and spending time with his wife and 2 children.   On the couch in this weeks' episode, Brandi and Stosh will tackle: The Heart of Success: A Leader's Guide to Highly Engaged Teams.   Links: Get in touch with Stosh Walsh on: LinkedIn Instagram Facebook Constant Organizational Development YouTube Podcast: Insubordinate Subscribe, listen, and rate/review Revenue Rehab Podcast on Apple Podcasts, Spotify, Google Podcasts , Amazon Music, or iHeart Radio and find more episodes on our website RevenueRehab.live